Plant MDL proteins synergize with the cytokine MIF at CXCR2 and CXCR4 receptors in human cells.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
21 Nov 2023
Historique:
medline: 23 11 2023
pubmed: 21 11 2023
entrez: 21 11 2023
Statut: ppublish

Résumé

Mammalian macrophage migration inhibitory factor (MIF) and its paralog, D-dopachrome tautomerase, are multifunctional inflammatory cytokines. Plants have orthologous MIF and D-dopachrome tautomerase-like (MDL) proteins that mimic some of the effects of MIF on immune cells in vitro. We explored the structural and functional similarities between the three

Identifiants

pubmed: 37988455
doi: 10.1126/scisignal.adg2621
doi:

Substances chimiques

Macrophage Migration-Inhibitory Factors 0
Plant Proteins 0
Receptors, CXCR4 0
MIF protein, human EC 5.3.2.1
Intramolecular Oxidoreductases EC 5.3.-
CXCR4 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg2621

Auteurs

Lukas Spiller (L)

Department of Pharmacology, School of Medicine, Yale University, New Haven, CT 06510, USA.
Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.

Ramu Manjula (R)

Department of Pharmacology, School of Medicine, Yale University, New Haven, CT 06510, USA.

Franz Leissing (F)

Unit of Plant Molecular Cell Biology, Institute for Biology I, RWTH Aachen University, 52056 Aachen, Germany.

Jerome Basquin (J)

Department of Structural Cell Biology and Crystallization Facility, Max-Planck-Institute for Biochemistry, 82152 Martinsried, Germany.

Priscila Bourilhon (P)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.

Dzmitry Sinitski (D)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.

Markus Brandhofer (M)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.

Sophie Levecque (S)

Unit of Plant Molecular Cell Biology, Institute for Biology I, RWTH Aachen University, 52056 Aachen, Germany.

Simona Gerra (S)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.

Björn Sabelleck (B)

Unit of Plant Molecular Cell Biology, Institute for Biology I, RWTH Aachen University, 52056 Aachen, Germany.

Lin Zhang (L)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.
Department of Anesthesiology, LMU University Hospital, 81377 Munich, Germany.

Regina Feederle (R)

Monoclonal Antibody Core Facility, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.
Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.

Andrew Flatley (A)

Monoclonal Antibody Core Facility, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.

Adrian Hoffmann (A)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.
Department of Anesthesiology, LMU University Hospital, 81377 Munich, Germany.

Ralph Panstruga (R)

Unit of Plant Molecular Cell Biology, Institute for Biology I, RWTH Aachen University, 52056 Aachen, Germany.

Jürgen Bernhagen (J)

Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU) München, LMU University Hospital, 81377 Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.

Elias Lolis (E)

Department of Pharmacology, School of Medicine, Yale University, New Haven, CT 06510, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH